Manel Azzi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Manel Azzi has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Abderrhmane Bouafia
Department of Process Engineering and Petrochemistry, Faculty of Technology, University of El Oued, El Oued, Algeria
1 shared publication - Ibtissam Laib
Faculty of Biology, Department of Cellular and Molecular Biology University of El Oued El Oued Algeria
1 shared publication - Laid Zeghoud
Department of Process Engineering and Petrochemistry Faculty of Technology University of El Oued El Oued Algeria
1 shared publication - Mohammed Adel Mesbahi
Laboratory of Applied Chemistry and Environment (LCAE), Faculty of Exact Sciences University of El Oued El Oued Algeria
1 shared publication - Mohammed Tayeb Oucif Khaled
Department of Process Engineering and Petrochemistry Faculty of Technology University of El Oued El Oued Algeria
1 shared publication - Salah Eddine Laouini
Department of Process Engineering and Petrochemistry, Faculty of Technology University of El Oued El Oued Algeria
1 shared publication
Latest Publications
- 11 August 2026
- Published by Wiley in Crystal Research and Technology
- Vol. 61 (8)
Multifunctional Ag/ZnO. Nanocomposites: Synthesis, Characterization, and Potent Antioxidant, Antibiofilm, and Anti‐Inflammatory Activities
Ag/ZnO nanocomposites have attracted significant interest due to their enhanced physicochemical properties and wide‐ranging biomedical applications. In this study, the nanocomposites were successfully synthesized and thoroughly characterized. X‐ray diffraction confirmed the presence of a highly crystalline hexagonal ZnO structure with incorporated metallic Ag nanoparticles; the crystallite size, determined by the Scherrer equation, was approximately 55 nm. Scanning electron microscopy revealed quasi‐spherical particles exhibiting uniform morphology and good dispersion. UV–Vis spectroscopy displayed a prominent absorption band at 383 nm and a narrowed optical band gap of 1.70 eV, indicating strong electronic interactions between Ag and ZnO, along with improved surface reactivity. Biological evaluation demonstrated potent multifunctional activities. In the DPPH assay, the nanocomposites showed concentration‐dependent antioxidant activity, achieving 79% radical scavenging at 400 µg/mL, with an IC 50 of 166.79 µg/mL. The FRAP assay confirmed strong reducing power, rising from 120.22 to 760.37 µM Fe 2 + /g with increasing concentration. The materials exhibited excellent antibiofilm effects against pathogenic bacteria, inhibiting biofilm formation by up to 90%. Additionally, they effectively inhibited protein denaturation in the anti‐inflammatory assay, yielding an IC 50 of 137.83 µg/mL. These findings underscore the substantial biomedical potential of Ag/ZnO nanocomposites.
- 11 August 2026
- Published by Wiley in Crystal Research and Technology
- Vol. 61 (8)
Multifunctional Ag/ZnO. Nanocomposites: Synthesis, Characterization, and Potent Antioxidant, Antibiofilm, and Anti‐Inflammatory Activities
Ag/ZnO nanocomposites have attracted significant interest due to their enhanced physicochemical properties and wide‐ranging biomedical applications. In this study, the nanocomposites were successfully synthesized and thoroughly characterized. X‐ray diffraction confirmed the presence of a highly crystalline hexagonal ZnO structure with incorporated metallic Ag nanoparticles; the crystallite size, determined by the Scherrer equation, was approximately 55 nm. Scanning electron microscopy revealed quasi‐spherical particles exhibiting uniform morphology and good dispersion. UV–Vis spectroscopy displayed a prominent absorption band at 383 nm and a narrowed optical band gap of 1.70 eV, indicating strong electronic interactions between Ag and ZnO, along with improved surface reactivity. Biological evaluation demonstrated potent multifunctional activities. In the DPPH assay, the nanocomposites showed concentration‐dependent antioxidant activity, achieving 79% radical scavenging at 400 µg/mL, with an IC 50 of 166.79 µg/mL. The FRAP assay confirmed strong reducing power, rising from 120.22 to 760.37 µM Fe 2 + /g with increasing concentration. The materials exhibited excellent antibiofilm effects against pathogenic bacteria, inhibiting biofilm formation by up to 90%. Additionally, they effectively inhibited protein denaturation in the anti‐inflammatory assay, yielding an IC 50 of 137.83 µg/mL. These findings underscore the substantial biomedical potential of Ag/ZnO nanocomposites.